Jefferies Group LLC Heron Therapeutics, Inc. Transaction History

Jefferies Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $360,338 - $985,448	-156,669 Closed	0 $0
Q1 2022 Sep 21, 2023	SELL	$4.63 - $9.94 $627,341 - $1.35 Million	-135,495 Reduced 52.11%	124,545 $712,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $478,607 - $1.03 Million	-103,371 Reduced 39.75%	156,669 $732,000
Q4 2021 Sep 21, 2023	BUY	$8.35 - $12.6 $2.17 Million - $3.28 Million	260,040 New	260,040 $2.37 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $1.9 Million - $2.87 Million	228,093 Added 713.97%	260,040 $2.37 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $75,783 - $181,940	7,408 Added 30.19%	31,947 $375,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $427,469 - $652,982	24,539 New	24,539 $577,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $140,837 - $204,639	-6,393 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $191,790 - $261,154	6,393 New	6,393 $202,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $217,474 - $339,840	-11,800 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $174,640 - $222,430	11,800	11,800 $214,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.